Selectis Health, INC
Market Movers (8-K)
OQB
Selectis Health, Inc. announced the resignation of CEO and CFO Adam Desmond, appointing Krystal Eckhart as interim CEO and CFO.
OQB
Selectis Health, Inc. has finalized the sale of two skilled nursing facilities in Georgia for $15.7 million.
OQB
David Furstenberg has resigned from Selectis Health, Inc.'s Board of Directors and Audit Committee, effective March 30, 2026.
OQB
Selectis Health, Inc. announced the sale of two skilled nursing facilities in Georgia for $13.175 million, aiming to reduce debt and bolster working capital.
OQB
Selectis Health, Inc. announced the appointment of Kent J. Lund and Lance Baller to its Board of Directors, effective January 1, 2026, bringing extensive legal, financial, and corporate governance expertise.
Better than expected
OQB
Selectis Health, Inc. has modified its 2018 Senior Secured Promissory Notes, extending the maturity date to February 28, 2026, increasing the interest rate to 13%, and appointing two new board members.
Worse than expected
Delay expected
Quarterly Earnings (10-Q)
OQB
Selectis Health reports a net income of $6.5 million for Q1 2026, driven primarily by asset sales, despite ongoing going concern uncertainties.
Better than expected
Capital raise
OQB
Selectis Health, Inc. reported a significant reduction in net loss for the nine months ended September 30, 2025, and a swing to net income for the third quarter, driven by increased healthcare revenue and employee retention credits, despite ongoing liquidity concerns and internal control weaknesses.
Delay expected
Better than expected
Capital raise
OQB
Selectis Health, Inc. reported a widened net loss and significant liquidity challenges for Q2 2025, raising substantial doubt about its ability to continue as a going concern.
Delay expected
Worse than expected
Capital raise
OQB
Selectis Health saw a revenue increase in Q1 2025, but continues to face net losses and substantial doubt about its ability to continue as a going concern.
Worse than expected
Capital raise
OQB
Selectis Health's Q3 2024 results show a net loss and negative operating cash flow, raising concerns about the company's ability to continue as a going concern, despite increased healthcare revenue.
Worse than expected
Capital raise
OQB
Selectis Health saw an increase in healthcare revenue for Q2 2024, but continues to face challenges related to internal controls and a going concern warning.
Worse than expected
Capital raise
Annual Reports (10-K)
OQB
Selectis Health reports a net loss of $1.0 million for 2025 and highlights substantial doubt regarding its ability to continue as a going concern.
Capital raise
OQB
Selectis Health saw a revenue increase in 2024, but faces significant financial challenges raising substantial doubt about its ability to continue as a going concern.
Worse than expected
OQB
10-K/A: Selectis Health Files Amended 10-K, Citing Internal Control Weaknesses and Operational Shifts
Selectis Health files an amended annual report, highlighting internal control deficiencies and a strategic shift towards operating its own healthcare facilities.
Worse than expected
Capital raise
OQB
Selectis Health's 2023 annual report reveals a transition towards an owner-operator model, impacting revenue streams and highlighting ongoing financial challenges.
Worse than expected
Capital raise
Insider Trading (Form 4)
OQB
Lance Baller, a Director and 10% owner of Selectis Health, Inc., purchased 6,192 shares of common stock at $2.20 per share.